Related Experiment Video
Updated: Jan 20, 2026
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Our experience with dermal substitute Nevelia® in the treatment of severely burned patients
Hakan Yiğitbaş1, Erkan Yavuz1, Evrim Beken Özdemir1
1Department of General Surgery, Health Sciences University Bağcılar Training and Research Hospital, İstanbul-Turkey.
Background:
This research aims to retrospectively evaluate the effectiveness and safety of dermal substitute (DS), Nevelia®, for the treatment of severely burned patients.
Methods:
Twenty severely burned patients were enrolled in this study between May 2017 and May 2018. After escharotomy of the wound, the treatment protocol was applied following a two-step procedure -DS implantation followed by split-thickness skin graft (STSG) application. Need for surgery, complications, hospitalisation duration and overall survival were analysed.
Results:
Mean age was 40.1±4 (18-86) years old; female/male: 5/15. Mean burn surface area was 50.1%±2 (25-96). Two patients died under hospital treatment due to the severity of their burn trauma and comorbidities. For the rest of the cases, STSG was performed after Nevelia® at mean 21.2 days. No complications due to Nevelia® were detected. The patients were discharged with a mean total recovery of 55.2±4 days.
Conclusion:
This study showed that Nevelia® can be used safely and effectively in severely burned patients with low complication rates and short hospital stay.
Related Concept Videos
11:39The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
07:45Severe Burn Injury in a Swine Model for Clinical Dressing Assessment
02:49A Swine Burn Model for Investigating the Healing Process in Multiple Depth Burn Wounds
08:40Rat Burn Model to Study Full-Thickness Cutaneous Thermal Burn and Infection
06:05Enema of Traditional Chinese Medicine for Patients with Severe Acute Pancreatitis
12:03Fertility Preservation in Patients with Severe Ovarian Dysfunction